Abstract
Objective To determine tissue-specific neurodegeneration across the spinal cord in patients with mild-moderate degenerative cervical myelopathy (DCM).
Methods Twenty-four mild-moderate DCM and 24 healthy subjects were recruited. In patients, a T2-weighted scan was acquired at the compression site, while in all participants a T2*-weighted and diffusion-weighted scan was acquired at the cervical level (C2-C3) and in the lumbar enlargement (i.e. rostral and caudal to the site of compression). We quantified intramedullary signal changes, maximal canal and cord compression, white (WM) and grey matter (GM) atrophy, and microstructural indices from diffusion-weighted scans. All patients underwent clinical (modified Japanese Orthopaedic Association (mJOA)) and electrophysiological assessments. Regression analysis assessed associations between MRI readouts and electrophysiological and clinical outcomes.
Results Twenty patients were classified with mild and four with moderate DCM using the mJOA scale. The most frequent site of compression was at C5-C6 level with maximum cord compression of 4.68±0.83 mm. Ten patients showed imaging evidence of cervical myelopathy. In the cervical cord, WM and GM atrophy and WM microstructural changes were evident, while in the lumbar cord only WM showed atrophy and microstructural changes. Remote cervical cord WM microstructural changes were pronounced in patients with radiological myelopathy and associated with impaired electrophysiology. Lumbar cord WM atrophy was associated with lower limb sensory impairments.
Conclusion Tissue-specific neurodegeneration revealed by quantitative MRI, already apparent across the spinal cord in mild-moderate DCM prior to the onset of severe clinical impairments. WM microstructural changes are particularly sensitive to remote pathologically and clinically eloquent changes in DCM.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study is funded by grants from Wings for life charity (INSPIRED) (No WFL-CH-007/14) ERA-NET NEURON (hMRIofSCI no: 32NE30_173678), the European Union's Horizon 2020 research and innovation program under the grant agreement No 681094, and the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number 15.0137, grants from International Foundation for Research (IRP-158). Spinal Research and Craig H. Neilsen Foundation (CHNF). MS is funded by the wings for life (No WFL-CH-19/20), P.S. is funded by the Eccellenza fellowship/181362 by SNSF.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was performed in accordance with the Declaration of Helsinki, approved by the local Ethics Committee of canton Zurich (EK-2010-0271).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Disclosure KV reports no disclosures. GD reports no disclosures. MH reports no disclosures. NP reports no disclosures. JC reports no disclosures. MF reports no disclosures RS reports no disclosures. CW reports no disclosures. AC reports no disclosures. PF reports no disclosures.MS reports no disclosures.
Author disclosures All authors declare no potential conflicts of interest with respect to research, authorship and/or publication of this article. Max Planck Institute for Human Cognitive and Brain Sciences and welcome trust center have an institutional research agreement with and receives support from Siemens Healthcare.
Data Availability
The authors certify they have documented all data, methods, and materials used to conduct the research presented. Anonymized data not published within this article will be made available by request from any qualified investigator.